Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Trupanion Inc. (TRUP:NASDAQ), powered by AI.
Trupanion Inc. is currently trading at $24.44. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Trupanion Inc. on Alpha Lenz.
Trupanion Inc.'s P/E ratio is 54.0.
“Trupanion Inc. trades at a P/E of 54.0 (premium valuation) with modest ROE of 5.5%. 3Y revenue CAGR of 16.7% highlights clear growth momentum.”
Ask for details →Trupanion Inc. offers health insurance plans tailored specifically for cats and dogs. Its primary mission is to provide pet owners with financial peace of mind by covering unexpected veterinary expenses. As a leader in the pet insurance industry, Trupanion addresses significant costs associated with pets' medical emergencies and ongoing care. The company distinguishes itself by offering comprehensive coverage, including surgeries, hospital stays, medications, and diagnostics. Trupanion Inc. primarily operates in North America and has a customer-centric approach with its direct-to-consumer model, enhancing customer experience and retention. The company has built partnerships with veterinary hospitals to facilitate direct payment of claims, reducing out-of-pocket expenses for pet owners. Trupanion forms part of the rapidly growing pet care market, driven by increasing pet ownership and awareness about the benefits of pet insurance. By combining technology with financial services, Trupanion plays a critical role in promoting responsible pet ownership while contributing to the broader ecosystem of pet healthcare.
“Trupanion Inc. trades at a P/E of 54.0 (premium valuation) with modest ROE of 5.5%. 3Y revenue CAGR of 16.7% highlights clear growth momentum.”
Ask for details →Trupanion Inc. (ticker: TRUP) is a company listed on NASDAQ in the Financial Services sector (Insurance - Property & Casualty). It has approximately 1,130 employees. Market cap is $1.0B.
The current price is $24.44 with a P/E ratio of 54.03x and P/B of 2.73x.
ROE is 5.50% and operating margin is 7.00%. Annual revenue is $1.4B.